| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Krystal Biotech, Inc. (KRYS) has 8 insiders with recent SEC Form 4 filings, including 7 buys and 39 sells. KRYS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.50M | $515.64M | - | |
| Pres | 1.43M | $490.87M | - | |
| Dir | 75.7K | $26.01M | - | |
| Dir | 5.0K | $1.72M | - | |
| Dir | 5.0K | $1.72M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2020 | Krishnan Suma46 | Chief Operating Officer | Sell | 15,398 | $40.49 | $623,411.71 | -0.2% | |
| Feb 20, 2020 | Krishnan Krish S46 | President And CEO | Sell | 50,000 | $62.06 | $3,102,895.66 | -0.3% | |
| Dec 18, 2019 | Krishnan Suma46 | Chief Operating Officer | Sell | 50,000 | $62.04 | $3,101,953.96 | -0.2% | |
| Nov 18, 2019 | Krishnan Krish S46 | President And CEO | Sell | 50,000 | $51.26 | $2,562,887.94 | -0.3% | |
| Aug 30, 2019 | Janney Daniel | Director | Sell | 88,684 | $46.46 | $4,120,342.54 | -7.1% | |
| Oct 18, 2018 | Krishnan Suma46 | Chief Operating Officer | Buy | 25,000 | $20.00 | $500,000.00 | +1.3% | |
| Oct 18, 2018 | Krishnan Krish S46 | President And CEO | Buy | 25,000 | $20.00 | $500,000.00 | +1.2% | |
| Jun 6, 2018 | Krishnan Suma46 | Chief Operating Officer | Buy | 25,000 | $11.02 | $275,609.26 | +0.4% | |
| May 22, 2018 | Riley Antony A65 | Chief Financial Officer | Buy | 2,800 | $10.75 | $30,100.00 | New | |
| May 9, 2018 | Norby R Douglas | Director | Buy | 9,000 | $10.42 | $93,780.00 | New |